Publications by authors named "Stuart A Montgomery"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

3,927

Total Likes

88

Extended Reach

4,188

Social Features

4
M
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.
Stuart A Montgomery, L J Thal, R Amrein

Int Clin Psychopharmacol· March 2003

Videos about Article: user user

2 2

View All Article and Social Media Activity
D
Depression with high levels of anxiety.
Stuart A Montgomery

Int Clin Psychopharmacol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysis.
Stuart A Montgomery, Gavin Lyndon, Mary Almas, Ed Whalen, Rita Prieto

Int Clin Psychopharmacol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.
Suresh Durgam, Willie Earley, Hua Guo, Dayong Li, György Németh, Stuart A Montgomery

J Clin Psychiatry· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant or antidepressant plus placebo effect?
Stuart A Montgomery

World Psychiatry· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials.
Stuart A Montgomery, Carl P Gommoll, Changzheng Chen, William M Greenberg

CNS Spectr· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.
David S Baldwin, Mary Green, Stuart A Montgomery

Int Clin Psychopharmacol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorder.
Stuart A Montgomery, Julie C Locklear, Henrik Svedsäter, Hans Eriksson

Int Clin Psychopharmacol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine.
Stuart A Montgomery, Rebecca Z Nielsen, Lis H Poulsen, Lars Häggström

Hum Psychopharmacol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
Connie Sanchez, Elin H Reines, Stuart A Montgomery

Int Clin Psychopharmacol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
Stuart A Montgomery, A Carlo Altamura, Heikki Katila, Catherine Datto, Johan Szamosi

Int Clin Psychopharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind, placebo-controlled study.
Stuart A Montgomery, Lucilla Mansuy, Adam C Ruth, Dayong Li, Carl Gommoll

Int Clin Psychopharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
Michael Bauer, Liliana Dell'osso, Siegfried Kasper, William Pitchot, Eva Dencker Vansvik, Stuart A Montgomery

J Affect Disord· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of levomilnacipran sustained release in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study.
Stuart A Montgomery, Lucilla Mansuy, Adam Ruth, Anjana Bose, Hua Li

J Clin Psychiatry· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control.
Siegfried Kasper, Emmanuelle Corruble, Anthony Hale, Patrick Lemoine, Stuart A Montgomery

Int Clin Psychopharmacol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of depressive symptoms in patients with coronary artery disease using the Montgomery Åsberg Depression Rating Scale.
Adomas Bunevicius, Margarita Staniute, Julija Brozaitiene, Antoinette M Pommer, Victor J M Pop, Stuart A Montgomery

Int Clin Psychopharmacol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
Richard H Weisler, Stuart A Montgomery, Willie R Earley, Johan Szamosi, Arthur Lazarus

Int Clin Psychopharmacol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desvenlafaxine for the prevention of relapse in major depressive disorder: results of a randomized trial.
Karl Rickels, Stuart A Montgomery, Karen A Tourian, Julien D Guelfi, Bruno Pitrosky

J Clin Psychopharmacol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder.
Stuart A Montgomery, Maurizio Fava, Sudharshan K Padmanabhan, Christine J Guico-Pabia, Karen A Tourian

Int Clin Psychopharmacol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Shen J, Kobak K, Zhao Y, et al. Use of remote centralized raters via live 2-way video ina multicenter clinical trial for schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693).
Heinz C R Grunze, Cyril Höschl, Stuart A Montgomery, Norman Sartorius, Eduard Vieta

J Clin Psychopharmacol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia.
Stuart A Montgomery, Barry K Herman, Edward Schweizer, Francine S Mandel

Int Clin Psychopharmacol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?
Stuart A Montgomery, Hans-Jürgen Möller

Int Clin Psychopharmacol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study.
Andrew J Cutler, Stuart A Montgomery, David Feifel, Arthur Lazarus, Mikael Aström

J Clin Psychiatry· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis